Vivo Opportunity Fund Holdings L.P. 13D and 13G filings for Gracell Biotechnologies Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Unchanged | 2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | Vivo Opportunity Fund Holdings L.P. | 38,152,030 7.700% | 0 (Unchanged) | Filing |
| 2023-08-18 4:56 pm Purchase | 2023-08-10 | 13G | Gracell Biotechnologies Inc. GRCL | Vivo Opportunity Fund Holdings L.P. | 38,152,030 7.800% | 38,152,030 (New Position) | Filing |